Search research articles
Contact Us
Filters
Showing results (91-100 of 275) with videos related to
Page
of 28
Sort By:
Toxicology
|
April 27, 2000
CYP2A6: a human coumarin 7-hydroxylase
O Pelkonen, A Rautio, H Raunio, et al.
British Journal of Clinical Pharmacology
|
October 27, 2001
Polymorphisms of CYP2A6 and its practical consequences
H Raunio, A Rautio, H Gullstén, et al.
Biochemical Pharmacology
|
January 15, 1982
Dissociation between ornithine decarboxylase activity and aryl hydrocarbon hydroxylase induction in cell cultures treated with benz[a]anthracene and inhibitors of ornithine decarboxylase
H Raunio, M Skurnik, P Korhonen, et al.
Cancer Research
|
October 1, 1977
Characterization of benzo(a)pyrene hydroxylase of trout liver
J T Ahokas, O Pelkonen, N T Kärki
IARC Scientific Publications
|
September 24, 1999
Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype
O Pelkonen, H Raunio, A Rautio, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 1, 1997
Regulation of CYP 2 A 5 induction by porphyrinogenic agents in mouse primary hepatocytes
P Salonpää, S Kottari, O Pelkonen, et al.
Toxicology
|
January 1, 1991
The cerium-induced liver injury and oxidative drug metabolism in DBA/2 and C57BL/6 mice
P Arvela, H Kraul, F Stenbäck, et al.
Life Sciences
|
May 1, 1975
Induction of aryl hydrocarbon hydroxylase in human fetal liver cell and fibroblast cultures by polycyclic hydrocarbons
O Pelkonen, P Korhonen, P Jouppila, et al.
Experientia
|
October 15, 1976
Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period
P Arvela, N T Kärki, R O Pelkonen
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 9, 2004
Cerebral CT and MRI findings in cervicocephalic artery dissection
O Pelkonen, T Tikkakoski, J Pyhtinen, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 275) with videos related to
Sort By:
Page
of 28
Toxicology
|
April 27, 2000
CYP2A6: a human coumarin 7-hydroxylase
O Pelkonen, A Rautio, H Raunio, et al.
British Journal of Clinical Pharmacology
|
October 27, 2001
Polymorphisms of CYP2A6 and its practical consequences
H Raunio, A Rautio, H Gullstén, et al.
Biochemical Pharmacology
|
January 15, 1982
Dissociation between ornithine decarboxylase activity and aryl hydrocarbon hydroxylase induction in cell cultures treated with benz[a]anthracene and inhibitors of ornithine decarboxylase
H Raunio, M Skurnik, P Korhonen, et al.
Cancer Research
|
October 1, 1977
Characterization of benzo(a)pyrene hydroxylase of trout liver
J T Ahokas, O Pelkonen, N T Kärki
IARC Scientific Publications
|
September 24, 1999
Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype
O Pelkonen, H Raunio, A Rautio, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 1, 1997
Regulation of CYP 2 A 5 induction by porphyrinogenic agents in mouse primary hepatocytes
P Salonpää, S Kottari, O Pelkonen, et al.
Toxicology
|
January 1, 1991
The cerium-induced liver injury and oxidative drug metabolism in DBA/2 and C57BL/6 mice
P Arvela, H Kraul, F Stenbäck, et al.
Life Sciences
|
May 1, 1975
Induction of aryl hydrocarbon hydroxylase in human fetal liver cell and fibroblast cultures by polycyclic hydrocarbons
O Pelkonen, P Korhonen, P Jouppila, et al.
Experientia
|
October 15, 1976
Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period
P Arvela, N T Kärki, R O Pelkonen
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 9, 2004
Cerebral CT and MRI findings in cervicocephalic artery dissection
O Pelkonen, T Tikkakoski, J Pyhtinen, et al.
Page
of 28